Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1967 1
1974 1
1982 1
1983 1
1984 1
1985 3
1986 6
1987 2
1988 3
1989 4
1990 1
1992 1
1993 3
1994 2
1995 2
1998 3
1999 1
2001 2
2002 2
2003 3
2004 4
2005 3
2006 7
2007 1
2008 9
2009 9
2010 11
2011 8
2012 3
2013 5
2014 9
2015 2
2016 5
2017 2
2018 9
2019 12
2020 8
2021 6
2022 4
2023 5
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

155 results

Results by year

Filters applied: . Clear all
Page 1
Gonadotropins.
[No authors listed] [No authors listed] 2018 Mar 26. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2018 Mar 26. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31644163 Free Books & Documents. Review.
Circulating human chorionic gonadotropin interacts with the luteinizing hormone receptors of the ovary, promoting the corpus luteum and its production of progesterone which is necessary to maintain pregnancy and support the growth of the fetus. ...The proper pulsati …
Circulating human chorionic gonadotropin interacts with the luteinizing hormone receptors of the ovary, promoting the corpus l …
Lutropin alfa.
Dhillon S, Keating GM. Dhillon S, et al. Drugs. 2008;68(11):1529-40. doi: 10.2165/00003495-200868110-00005. Drugs. 2008. PMID: 18627209 Review.
Dose-finding studies revealed a significant dose-dependent increase in the rate of optimal follicular development among women with hypogonadotropic hypogonadism and profound LH deficiency (<1.2 IU/L) who received subcutaneous lutropin alfa 0-225 IU/day plus follitropin …
Dose-finding studies revealed a significant dose-dependent increase in the rate of optimal follicular development among women with hypogonad …
The optimal choice of medication administration route regarding intravenous, intramuscular, and subcutaneous injection.
Jin JF, Zhu LL, Chen M, Xu HM, Wang HF, Feng XQ, Zhu XP, Zhou Q. Jin JF, et al. Patient Prefer Adherence. 2015 Jul 2;9:923-42. doi: 10.2147/PPA.S87271. eCollection 2015. Patient Prefer Adherence. 2015. PMID: 26170642 Free PMC article. Review.
RESULTS: "SC better than IV" involves trastuzumab, rituximab, antitumor necrosis factor medications, bortezomib, amifostine, recombinant human granulocyte-macrophage colony-stimulating factor, granulocyte colony-stimulating factor, recombinant interleukin-2, immunoglobulin, epoet …
RESULTS: "SC better than IV" involves trastuzumab, rituximab, antitumor necrosis factor medications, bortezomib, amifostine, recombinant hum …
Human choriogonadotropin and epoetin alfa in acute ischemic stroke patients (REGENESIS-LED trial).
Cramer SC, Hill MD; REGENESIS-LED Investigators. Cramer SC, et al. Int J Stroke. 2014 Apr;9(3):321-7. doi: 10.1111/ijs.12260. Epub 2014 Mar 3. Int J Stroke. 2014. PMID: 24588854 Clinical Trial.
INTRODUCTION: Preclinical studies suggest that growth factors in the early days after stroke improve final outcome. A prior study found three doses of human choriogonadotropin alfa followed by three doses of erythropoietin to be safe after stroke in humans. ...Patie …
INTRODUCTION: Preclinical studies suggest that growth factors in the early days after stroke improve final outcome. A prior study found thre …
Dose accuracy of the follitropin alfa pen injector 2.0, the follitropin alfa:lutropin alfa 2:1 combination pen injector 2.0 and the choriogonadotropin alfa pen injector 1.0 used for fertility treatment.
Cottell E, Michalet D, Lispi M, Araujo TD, Gleixner R, Longobardi S, D'Hooghe T. Cottell E, et al. Expert Opin Drug Deliv. 2024 Feb;21(2):337-346. doi: 10.1080/17425247.2024.2311127. Epub 2024 Feb 2. Expert Opin Drug Deliv. 2024. PMID: 38299472
RESEARCH DESIGN AND METHODS: Set doses (V(set)) for three dose dial settings (minimum dose [V(min)], midpoint dose [V(mid)] and maximum dose [V(max)] for the follitropin alfa, choriogonadotropin alfa [D2 classification: single use/variable dose], and follitro …
RESEARCH DESIGN AND METHODS: Set doses (V(set)) for three dose dial settings (minimum dose [V(min)], midpoint dose [V(mid)] and maximum dose …
Development and Characterization of Saturated Fatty Acid-Engineered, Silica-Coated Lipid Vesicular System for Effective Oral Delivery of Alfa-Choriogonadotropin.
Shah V, Jobanputra A, Saxena B, Nivsarkar M. Shah V, et al. AAPS PharmSciTech. 2021 Mar 29;22(3):118. doi: 10.1208/s12249-021-01985-0. AAPS PharmSciTech. 2021. PMID: 33782790
The present study was designed to develop an efficient, safe, and patient-friendly dosage form, for oral delivery of alfa-choriogonadotropin, used in the treatment of female reproductive infertility. ...Silica-coated, DPPC-based NLVs imparted physicochemical stabili …
The present study was designed to develop an efficient, safe, and patient-friendly dosage form, for oral delivery of alfa-choriogo …
Corifollitropin alfa for female infertility.
Rombauts L, Talmor A. Rombauts L, et al. Expert Opin Biol Ther. 2012 Jan;12(1):107-12. doi: 10.1517/14712598.2012.641530. Epub 2011 Nov 30. Expert Opin Biol Ther. 2012. PMID: 22129170 Review.
Urinary-derived and recombinant FSH (rFSH) preparations are widely used in infertility treatment but have to be administered daily to achieve steady-state serum levels. Corifollitropin alfa is a hybrid molecule with a prolonged half-life. AREAS COVERED: The development and …
Urinary-derived and recombinant FSH (rFSH) preparations are widely used in infertility treatment but have to be administered daily to achiev …
Corifollitropin alfa: a review of its use in controlled ovarian stimulation for assisted reproduction.
Croxtall JD, McKeage K. Croxtall JD, et al. BioDrugs. 2011 Aug 1;25(4):243-54. doi: 10.2165/11206890-000000000-00000. BioDrugs. 2011. PMID: 21815699 Review.
Corifollitropin alfa (Elonva) is a fusion product of human follicle-stimulating hormone (FSH) and the C-terminal peptide of the beta-subunit of human chorionic gonadotropin (hCG) produced by recombinant DNA technology. ...Corifollitropin alfa is indica …
Corifollitropin alfa (Elonva) is a fusion product of human follicle-stimulating hormone (FSH) and the C-terminal peptide of the beta- …
Corifollitropin alfa, a long-acting follicle-stimulating hormone agonist for the treatment of infertility.
Loutradis D, Drakakis P, Vlismas A, Antsaklis A. Loutradis D, et al. Curr Opin Investig Drugs. 2009 Apr;10(4):372-80. Curr Opin Investig Drugs. 2009. PMID: 19337959 Review.
The agent comprises an alpha-subunit, which is identical to that of FSH, and a beta-subunit, which is produced by the fusion of the C-terminal peptide from the beta-subunit of chorionic gonadotropin to the beta-subunit of FSH. Corifollitropin alfa has a longe …
The agent comprises an alpha-subunit, which is identical to that of FSH, and a beta-subunit, which is produced by the fusion of the C-termin …
155 results